Cargando…
Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022
PURPOSE OF REVIEW: Historically, kidney cancer was diagnosed as either clear cell renal carcinoma (ccRCC) or non-clear cell renal carcinoma (nccRCC). With further research into the pathophysiology of nccRCC, multiple distinct subtypes have emerged creating distinct diagnosis, such as papillary renal...
Autor principal: | Maughan, Benjamin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468090/ https://www.ncbi.nlm.nih.gov/pubmed/35438388 http://dx.doi.org/10.1007/s11912-022-01269-1 |
Ejemplares similares
-
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
por: Rossi, Ernesto, et al.
Publicado: (2021) -
The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017) -
Radionuclide Therapies in Prostate Cancer: Integrating Radium-223 in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
por: Nilsson, Sten
Publicado: (2016) -
Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality
por: Langlais, Crystal S., et al.
Publicado: (2021) -
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
por: Al Hussein Al Awamlh, Bashir, et al.
Publicado: (2022)